Flu fighter: Nanoparticle-based vaccine effective in preclinical trials (IMAGE)
Caption
The circle-shaped objects in the image above are cobalt-porphyrin-phospholipid (CoPoP) nanoparticles decorated with flu proteins.
Credit
University at Buffalo.
Usage Restrictions
None
License
Licensed content